Genemarkers has seen a surge in business due to COVID-19 testing.
KALAMAZOO, Mich. The expansion of COVID-19 testing, while playing a large part in pandemic mitigation strategies across Michigan, also fueled genomics research company Genemarkers exponential growth. It s an accomplishment being celebrated by the Biosciences Research and Commercialization Center (BRCC) of Western Michigan University a nonprofit that invests in early stage life science startups across the state.
Genemarkers, which applies state-of-the-art genomics technologies to research and development, initially formed a solid foundation in the skin care industry before diversifying into clinical genetic testing. The company found itself uniquely positioned to make a pandemic pivot when novel coronavirus cases began surging in the spring of 2020.